Quick Takeaways
- Kynam Capital Management, LP filed SCHEDULE 13G for Cullinan Therapeutics, Inc. Common Stock, par value $0.0001 per share (CGEM).
- Disclosed ownership: 5.3%.
- Date of event: 31 Dec 2025.
Kynam Capital Management, LP - 31 Dec 2025 SCHEDULE 13G Report for Cullinan Therapeutics, Inc. Common Stock, par value $0.0001 per share (CGEM)
- Filing Manager
- Kynam Capital Management, LP
- Reporting Manager
- Kynam Capital Management, LP
- Symbol
- CGEM
- Shares outstanding
- 59,091,689 shares
- Disclosed Ownership
- 3,114,132 shares
- Ownership
- 5.3%
- Form type
- SCHEDULE 13G
- Filing time
- 04 Mar 2026, 15:16:34 UTC
- Date of event
- 31 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Kynam Capital Management, LP disclosed 5.3% ownership in Cullinan Therapeutics, Inc. Common Stock, par value $0.0001 per share (CGEM) on 31 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 04 Mar 2026, 15:16.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Kynam Capital Management, LP | 5.3% | 3,114,132 | 0 | 3,114,132 | Yue Tang | Managing Member | |
| Kynam Capital Management GP, LLC | 5.3% | 3,114,132 | 0 | 3,114,132 | Yue Tang | Managing Member | |
| Yue Tang | 5.3% | 3,114,132 | 0 | 3,114,132 | Yue Tang | Self |